LENZ
LENZ Therapeutics, Inc.Company with tickers: LENZ
CIK
1815776
CUSIP
52635N103
Shares Outstanding
31,354,394
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $0 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $5,818,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-16,931,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-14,619,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.53 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.53 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |